Allergan Sales Decline in Second Quarter

Allergan Inc. reported second quarter net income of $21.4 million, or 33 cents a share, as sales declined 2%.

For the second quarter last year, the health care company earned $700,000, or 1 cent a share, after $34.2 million in charges for restructuring and $6.7 million in asset write-offs.

Sales dropped to $284.5 million from $289.6 million. The company, which makes therapeutic eye and skin-care products, attributed the decline to foreign currency fluctuations.

Net income for the first half rose 65% to $39.2 million, or 60 cents a share, from $23.8 million, or 36 cents a share, for the comparable six months last year. Sales dropped 1% to $540.7 million from $547.7 million.